Find an Article

Filter articles

Applied Filters

Showing 41 to 42 of 42 results

Australia: the Myriad case


The Federal Court in Australia has ruled in Cancer Voices Australia v. Myriad Genetics that isolated genetic material is patentable in Australia. Karen Sinclair explains the relevant issues.

Banning the patenting of biological materials in Australia: fact v fiction

Australia01-05-2011Tania Obranovich

An Australian legislative bill could have grave consequences for the country’s life sciences industry and, potentially, for patients as well. Tania Obranovich explains.

Showing 41 to 42 of 42 results